Description
Quad-X is a research material intended for controlled laboratory settings where all four constituents are used in combination. Each component is individually characterized prior to blending; lot documentation reflects the source materials.
The molar spread here is the widest of any blend in the catalog — from 333 to 4,963 g/mol, roughly 15-fold. Despite equal 20 mg mass loading, the molar ratio is approximately 15:15:3.5:1 (Cartalax : KPV : PDA : TB-4). Equal mass is not equal molar quantity, and this matters when calculating exposure in a dose–response design.
Documentation such as COA, HPLC chromatograms, and LC-MS data may be available on a lot basis where applicable. Request documentation by emailing connect@novuspeptides.com with the catalog number and required tests.
This product is sold strictly for laboratory research use only and is not intended for human or veterinary administration. Buyer is responsible for lawful handling, storage, and use in accordance with all applicable regulations.
Technical Summary
- Catalog #:QUAD-X
- Form:Lyophilized Powder (80 mg total)
- Purity:≥ 99%
- Verification:HPLC / LC-MS
- CAS Number:Mixture — see components
- Molecular Weight:Mixture — see components
- Molecular Formula:Mixture — see components
- Component 1 — PDA (Pentadeca Arginate):20 mg · GEPPPGKPADDAGLV, arginine salt · peptide CAS 137525-51-0 · C62H98N16O22 · 1419.55 g/mol (free peptide)
- Component 2 — TB-4 (Thymosin β4):20 mg · CAS 77591-33-4 · C212H350N56O78S · 4963.44 g/mol
- Component 3 — KPV:20 mg · CAS 67727-97-3 · C16H30N4O4 · 342.44 g/mol · Lys-Pro-Val
- Component 4 — Cartalax (AED):20 mg · C12H19N3O8 · 333.29 g/mol · Ala-Glu-Asp · PubChem CID 87815447
- Appearance:White Lyophilized Powder
